The Impact of Market Fluctuations on Gilead Sciences, Inc.’s (GILD) Stock
The stock of Gilead Sciences, Inc. (GILD) has gone down by -2.17% for the week, with a -10.36% drop in the past month and a
The stock of Gilead Sciences, Inc. (GILD) has gone down by -2.17% for the week, with a -10.36% drop in the past month and a
The stock of Gilead Sciences, Inc. (GILD) has seen a -5.01% decrease in the past week, with a -4.20% drop in the past month, and
In the past week, GILD stock has gone up by 0.22%, with a monthly gain of 0.76% and a quarterly plunge of -8.86%. The volatility
The price-to-earnings ratio for Gilead Sciences, Inc. (NASDAQ: GILD) is above average at 16.12x. The 36-month beta value for GILD is also noteworthy at 0.20.
In the past week, GILD stock has gone down by -1.47%, with a monthly decline of -0.23% and a quarterly plunge of -7.61%. The volatility
The stock of Gilead Sciences, Inc. (GILD) has seen a -1.90% decrease in the past week, with a 0.89% gain in the past month, and
Eli Lilly (LLY) stock gained 1.4% on Friday. The Indianapolis laboratory sought an emergency use authorization from the U.S. Food & Drug Administration for its
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.